Press Release Relmada Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update 2 hours ago
Press Release Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer Jul 28